首页> 外文期刊>American Journal of Physiology >Effects of thrombin inhibition with melagatran on renal hemodynamics and function and liver integrity during early endotoxemia.
【24h】

Effects of thrombin inhibition with melagatran on renal hemodynamics and function and liver integrity during early endotoxemia.

机译:melagatran抑制凝血酶对早期内毒素血症期间肾脏血液动力学和功能以及肝脏完整性的影响。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Sepsis is associated with an activation of the coagulation system and multiorgan failure. The aim of the study was to examine the effects of selective thrombin inhibition with melagatran on renal hemodynamics and function, and liver integrity, during early endotoxemia. Endotoxemia was induced in thiobutabarbital-anesthetized rats by an intravenous bolus dose of lipopolysaccharide (LPS; 6 mg/kg). Sham-Saline, LPS-Saline, and LPS-Melagatran study groups received isotonic saline or melagatran immediately before (0.75 micromol/kg iv) and continuously during (0.75 micromol.kg(-1).h(-1) iv) 4.5 h of endotoxemia. Kidney function, renal blood flow (RBF), and intrarenal cortical and outer medullary perfusion (OMLDF) measured by laser-Doppler flowmetry were analyzed throughout. Markers of liver injury and tumor necrosis factor (TNF)-alpha were measured in plasma after 4.5 h of endotoxemia. In addition, liver histology and gene expression were examined. Melagatran treatment prevented the decline in OMLDF observedin the LPS-Saline group (P < 0.05, LPS-Melagatran vs. LPS-Saline). However, melagatran did not ameliorate reductions in mean arterial pressure, RBF, renal cortical perfusion, and glomerular filtration rate or attenuate tubular dysfunctions during endotoxemia. Melagatran reduced the elevated plasma concentrations of aspartate aminotransferase (-34 +/- 11%, P < 0.05), alanine aminotransferase (-21 +/- 7%, P < 0.05), bilirubin (-44 +/- 9%, P < 0.05), and TNF-alpha (-32 +/- 14%, P < 0.05) in endotoxemia. Melagatran did not diminish histological abnormalities in the liver or the elevated hepatic gene expression of TNF-alpha, intercellular adhesion molecule-1, and inducible nitric oxide synthase in endotoxemic rats. In summary, thrombin inhibition with melagatran preserved renal OMLDF, attenuated liver dysfunction, and reduced plasma TNF-alpha levels during early endotoxemia.
机译:败血症与凝血系统的激活和多器官衰竭有关。这项研究的目的是研究在早期内毒素血症期间,使用美拉加群选择性抑制凝血酶对肾脏血液动力学和功能以及肝脏完整性的影响。静脉推注剂量的脂多糖(LPS; 6 mg / kg)在硫代丁巴比妥麻醉的大鼠中诱发内毒素血症。 Sham-Saline,LPS-Saline和LPS-Melagatran研究组在(0.75 micromol.kg(kg)iv)之前和之后(0.75 micromol.kg(-1).h(-1)iv)4.5 h连续接受等渗盐水或美拉加群内毒素血症。全文分析了通过激光多普勒血流仪测量的肾功能,肾血流量(RBF)以及肾内皮质和髓外灌注(OMLDF)。内毒素血症4.5小时后,在血浆中测量肝损伤和肿瘤坏死因子(TNF)-α的标志物。另外,检查了肝组织学和基因表达。 Melagatran治疗可防止LPS-盐水组中的OMLDF下降(P <0.05,LPS-Melagatran与LPS-盐水相比)。但是,美拉加群并没有改善内毒素血症期间平均动脉压,RBF,肾皮质灌注和肾小球滤过率的降低或肾小管功能障碍的减轻。 Melagatran降低了血浆中天冬氨酸转氨酶(-34 +/- 11%,P <0.05),丙氨酸转氨酶(-21 +/- 7%,P <0.05),胆红素(-44 +/- 9%,P <0.05)和内毒素血症中的TNF-α(-32 +/- 14%,P <0.05)。 Melagatran不会减轻内毒素血症大鼠肝脏中的组织学异常或TNF-α,细胞间粘附分子-1和诱导型一氧化氮合酶的肝基因表达升高。总之,在早期内毒素血症期间,用美拉加群抑制凝血酶可保留肾脏OMLDF,减轻肝功能障碍并降低血浆TNF-α水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号